Biomet Biologics

Biomet Biologics, a subsidiary of Zimmer Biomet, is a prominent developer of orthobiologics and regenerative medicine solutions. The company specializes in autologous therapies that harness a patient's own blood or bone marrow to treat musculoskeletal conditions, including platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) systems. Their portfolio includes the nSTRIDE Autologous Protein Solution, designed to treat knee osteoarthritis by neutralizing inflammatory cytokines. Additionally, Biomet Biologics provides a range of bone graft substitutes and soft tissue repair products used in orthopedic and spinal surgeries. The company's technologies are focused on enhancing the body's natural healing response and improving clinical outcomes in sports medicine and trauma.